News

The American Journal of Managed Care6d
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...
Newseria BIZNES18h
Myasthenia Gravis Treatment Market anticipated to reach US$2.785 billion by 2030 at a CAGR of 7.14%
The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...
BERNAMA4d
Living With Myasthenia Gravis, A Rare But Manageable Condition
As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...
Medscape10d
FDA OKs Vyvgart Hytrulo Prefilled Syringe for Generalized Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy
The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for ...
manilatimes17d
Johnson & Johnson highlights new data, demonstrating long-term sustained disease control in adults living with generalised myasthenia gravis (gMG)
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension ...
Seeking Alpha17d
Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia ...
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label ...
Mena FN17d
Johnson & Johnson Highlights New Data, Demonstrating Long-Term Sustained Disease Control In Adults Living With Generalised Myasthenia Gravis (Gmg)
Development of generalized disease at 2 years in patients ... 23 Cleveland Clinic. Myasthenia Gravis: Treatment & Symptoms. Available at: . Last accessed: April 2025 24 O'Connell K, Ramdas S ...